Hugo ten Cate, MD, PhD, FAHA

Professor, MD, PhD
Thrombosis Expertise Center, Heart & Vascular Center, Maastricht University Medical Center, Maastricht, the Netherlands

Hugo ten Cate
Graduated in medicine at the University of Amsterdam in 1987 and obtained a PhD degree based on an academic thesis on the Clinical and experimental studies with a low molecular weight heparinoid, at the University of Amsterdam in 1987. Between 1988 and1990 he was a postdoctoral fellow at the laboratory of prof Robert D Rosenberg and dr. Kenneth A Bauer, Beth Israel Hospital and Harvard Medical School Boston where he studied mechanisms of thrombosis using novel coagulation activation markers. Next, he completed training in Internal medicine at Slotervaart hospital and Academic Medical Center Amsterdam, combining it with translational research at Sanquin (prof Erik Hack) and at the Academic Medical Center (laboratory of Experimental Internal medicine, prof Pieter Reitsma). After being awarded a Clinical Established Investigatorship from the Dutch Heart Foundation he joined the Maastricht University Medical Center (MUMC+) and Cardiovascular Research Institute (CARIM) in 2002 as a Principal investigator and Professor in Internal medicine, particularly in Clinical Thrombosis and Haemostasis. He is the Director of the Maastricht Thrombosis Expertise Center, at the Heart and Vascular Center, MUMC+, a staff member of the division of Vascular Medicine, dept. of Internal medicine and Division leader Blood and board member CARIM. Between 2012 and 2016 he was a Fellow of the Gutenberg Research College, Gutenberg University and since 2017 Adjunct-professor, Center for Thrombosis and Haemostasis (CTH), Gutenberg University Medical Center, Mainz, Germany.
His main lines of research center around mechanisms of venous and arterial thrombosis, which he explores in translational research within several (inter)national consortia. He published over 450 articles.

Presentation(s):

• OC 17.4 - Effects of andexanet alfa on different thrombin generation and anti-Xa-methods in vitro.

  Sunday, July 10, 2022
  11:30 AM – 11:45 AM

• OC 23.5 - Identifying phenotypes of deep vein thrombosis and their relation to clinical outcomes beyond recurrence

  Sunday, July 10, 2022
  3:45 PM – 4:00 PM

• PB0062 - Rotational thromboelastometry in heparin monitoring in critical COVID-19 disease.

  Sunday, July 10, 2022
  6:30 PM – 7:30 PM

• PB0097 - Serial thrombin generation, while on LMWH prophylaxis in critically ill COVID-19 patients from the prospective MaastrICCht cohort.

  Sunday, July 10, 2022
  6:30 PM – 7:30 PM

• PB0407 - Establishing the signalling pathways regulating reversible platelet integrin activation

  Sunday, July 10, 2022
  6:30 PM – 7:30 PM

• VPB0372 - Subtype-specific plasma signatures of platelet-related protein releasate in acute pulmonary embolism

  Sunday, July 10, 2022
  6:30 PM – 7:30 PM

• PB0582 - Elevated contact pathway activity in patients with acute venous thromboembolism

  Monday, July 11, 2022
  6:30 PM – 7:30 PM

• PB0846 - ZO-2 Enriched Tight Junction-like Structures at Sites of Platelet-Platelet Contact

  Monday, July 11, 2022
  6:30 PM – 7:30 PM

• PB0853 - The potential of pre-activated platelets to contribute to thrombus formation

  Monday, July 11, 2022
  6:30 PM – 7:30 PM

• PB0870 - Platelet functional phenomics in the post-acute stage of pulmonary embolism

  Monday, July 11, 2022
  6:30 PM – 7:30 PM

• PB1043 - Complementary roles of red blood cells and platelets in high-throughput whole-blood thrombin generation

  Tuesday, July 12, 2022
  6:30 PM – 7:30 PM

• PB1336 - Clustering of coagulation factors in acute venous thromboembolism identifies clusters of thromboinflammatory and endothelial activation markers as independent predictors of recurrence and mortality.

  Tuesday, July 12, 2022
  6:30 PM – 7:30 PM

• SOA 26.4 - Advances in Thromboembolic Stroke Prevention and Management

  Wednesday, July 13, 2022
  8:30 AM – 9:45 AM